Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics

Medicine and Dentistry

• Biological Marker 100%
• Broad-Spectrum Antibiotic 100%
• Hazard Ratio 33%
• Randomized Controlled Trial 33%
• Cumulative Incidence 33%
• Urinary System 33%
• Cohort Study 33%
• Antibiotic Therapy 33%
• RNA Gene 33%
• Penicillin 33%
• Gut Microbiota 33%
• Carbapenem 33%
• Cephalosporin Derivative 33%
• Carbapenem Derivative 33%
• Quinolone Derivative 33%
• Enterococcus 33%
• Ruminococcus 33%
• Indican 33%
• β-Lactamase inhibitor 33%
• Beta Lactamase Inhibitor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antibiotics 100%
• Biological Marker 100%
• Cohort Study 33%
• Randomized Controlled Trial 33%
• Carbapenem 33%
• Carbapenem Derivative 33%
• Clindamycin 33%
• Cephalosporin Derivative 33%
• Intestine Flora 33%
• Ribosome RNA 33%
• Quinolone Derivative 33%
• Enterococcus 33%
• Ruminococcus 33%
• Indican 33%
• Beta Lactamase Inhibitor 33%
• Penicillin 33%

Immunology and Microbiology

• Intestine Flora 100%
• Enterococcus 100%
• RNA Gene 100%
• Ruminococcus 100%